Molecular Data Inc. (MKD) EPS growth this year is -51.20%: Get Prepared for Trading Lift Off
Molecular Data Inc. (NASDAQ: MKD) open the trading on June 09, 2021, with a bit cautious approach as it glided -8.42% to $0.86. During the day, the stock rose to $0.923 and sunk to $0.86 before settling in for the price of $0.94 at the close. Taking a more long-term approach, MKD posted a 52-week range of $0.73-$3.89.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -51.20%. This publicly-traded company’s shares outstanding now amounts to $116.90 million, simultaneously with a float of $109.67 million. The organization now has a market capitalization sitting at $121.37 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8884, while the 200-day Moving Average is $1.1112.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 189 workers. It has generated 5,823,137 per worker during the last fiscal year. Meanwhile, its income per employee was -251,431. The stock had 49.59 Receivables turnover and 12.55 Total Asset turnover. For the Profitability, stocks gross margin was -0.13, operating margin was -4.36 and Pretax Margin of -4.28.
Molecular Data Inc. (MKD) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Chemicals industry. Molecular Data Inc.’s current insider ownership accounts for 10.08%, in contrast to 15.60% institutional ownership.
Molecular Data Inc. (MKD) Earnings and Revenue Records
This company achieved a net margin of -4.32. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
Molecular Data Inc.’s EPS decrease for this current 12-month fiscal period is -51.20% and is forecasted to reach -0.06 in the upcoming year.
Molecular Data Inc. (NASDAQ: MKD) Trading Performance Indicators
Let’s observe the current performance indicators for Molecular Data Inc. (MKD). It’s Quick Ratio in the last reported quarter now stands at 1.00. The Stock has managed to achieve an average true range (ATR) of 0.06. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.10.
In the same vein, MKD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.44, a figure that is expected to reach -0.06 in the next quarter, and analysts are predicting that it will be -0.06 at the market close of one year from today.
Technical Analysis of Molecular Data Inc. (MKD)
[Molecular Data Inc., MKD] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 58.03% While, its Average True Range was 0.0608.
Raw Stochastic average of Molecular Data Inc. (MKD) in the period of the previous 100 days is set at 8.66%, which indicates a major fall in contrast to 51.60% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 88.39% that was lower than 104.27% volatility it exhibited in the past 100-days period.